$YJGJ
YIJIA GROUP CORP.

2023 Q2 Form 10-K Financial Statement

#000168316823003352 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 2022
Revenue $3.000K $38.00K $120.0K
YoY Change -93.33% -68.33%
Cost Of Revenue $0.00
YoY Change
Gross Profit $38.00K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $7.390K $62.23K $133.4K
YoY Change -89.71% -53.34% 156.04%
% of Gross Profit 163.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $7.390K $62.23K $133.4K
YoY Change -89.71% -53.34% 156.04%
Operating Profit -$24.23K -$13.37K
YoY Change 81.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$4.390K -$24.23K $139.7K
YoY Change -83.63% -117.34% -368.15%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.390K -$24.23K $139.7K
YoY Change -83.63% -117.34% -368.15%
Net Earnings / Revenue -146.33% -63.76% 116.4%
Basic Earnings Per Share $0.00 $0.02
Diluted Earnings Per Share $0.00 $0.00 $23.79K
COMMON SHARES
Basic Shares Outstanding 5.871M shares 5.871M shares 5.871M shares
Diluted Shares Outstanding 5.871M shares 5.871M shares

Balance Sheet

Concept 2023 Q2 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.730K $8.730K $23.10K
YoY Change -62.21% -62.21%
Cash & Equivalents $8.728K $8.730K $23.10K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables $0.00
Total Short-Term Assets $8.728K $8.730K $23.10K
YoY Change -62.22% -62.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $8.728K $8.730K $23.10K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $8.728K $8.730K $23.10K
YoY Change -62.22% -62.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $67.94K $67.94K $58.09K
YoY Change 16.96% 16.96% -66.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $67.94K $67.94K $58.09K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $67.94K $67.94K $58.09K
YoY Change 16.96% 16.96% -66.74%
SHAREHOLDERS EQUITY
Retained Earnings -$123.9K
YoY Change 24.3%
Common Stock $5.871K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$59.22K -$59.22K -$34.99K
YoY Change
Total Liabilities & Shareholders Equity $8.728K $8.730K $23.10K
YoY Change -62.22% -62.21%

Cashflow Statement

Concept 2023 Q2 2023 2022
OPERATING ACTIVITIES
Net Income -$4.390K -$24.23K $139.7K
YoY Change -83.63% -117.34% -368.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$2.290K -$18.38K $4.060K
YoY Change -83.44% -552.59% -109.6%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $4.000K 19.04K
YoY Change -78.99% -54.98%
NET CHANGE
Cash From Operating Activities -2.290K -$18.38K 4.060K
Cash From Investing Activities
Cash From Financing Activities 0.000 $4.000K 19.04K
Net Change In Cash -2.290K -$14.38K 23.10K
YoY Change -83.44% -162.23%
FREE CASH FLOW
Cash From Operating Activities -$2.290K -$18.38K $4.060K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001699709
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-04-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-218733
CY2023 dei Entity Registrant Name
EntityRegistrantName
Yijia Group Corp.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2583762
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
30 N Gould St
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 22545
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Sheridan
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
WY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
82801
CY2023 dei City Area Code
CityAreaCode
310
CY2023 dei Local Phone Number
LocalPhoneNumber
266-3738
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5871250 shares
CY2023 dei Auditor Name
AuditorName
OLAYINKA OYEBOLA & CO.
CY2023 dei Auditor Firm
AuditorFirmId
5968
CY2023 dei Auditor Location
AuditorLocation
Lagos, Nigeria
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8728 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23103 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
8728 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
23103 usd
CY2023Q2 us-gaap Assets
Assets
8728 usd
CY2022Q2 us-gaap Assets
Assets
23103 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
51843 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
45991 usd
CY2023Q2 YJGJ Amount Due To Related Party Current
AmountDueToRelatedPartyCurrent
16100 usd
CY2022Q2 YJGJ Amount Due To Related Party Current
AmountDueToRelatedPartyCurrent
12100 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
67943 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58091 usd
CY2023Q2 us-gaap Liabilities
Liabilities
67943 usd
CY2022Q2 us-gaap Liabilities
Liabilities
58091 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5871 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
5871 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58824 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58824 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123910 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99683 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34988 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8728 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23103 usd
CY2023 us-gaap Revenues
Revenues
38000 usd
CY2022 us-gaap Revenues
Revenues
120000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62227 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
133367 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
62227 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
133367 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-24227 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-13367 usd
CY2023 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
0 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
153049 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24227 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
139682 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24227 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
139682 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5871250 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5871250 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-174670 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
139682 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-34988 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24227 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-59215 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24227 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
139682 usd
CY2023 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-0 usd
CY2022 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
153049 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
5852 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20933 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
17428 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18375 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4061 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
19042 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19042 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14375 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
23103 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23103 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8728 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23103 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-24227 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123910 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26021 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20933 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zf6ncNUKWUy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86B_zO17zGY3wrG7">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5871250 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5871250 shares
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26021 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20933 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5088 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
65586 usd
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
123910 usd
CY2022Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
99683 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
123910 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
99683 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
26021 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
0001683168-23-003352-index-headers.html Edgar Link pending
0001683168-23-003352-index.html Edgar Link pending
0001683168-23-003352.txt Edgar Link pending
0001683168-23-003352-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yijia_ex3101.htm Edgar Link pending
yijia_ex3201.htm Edgar Link pending
yijia_i10k-043023.htm Edgar Link pending
yjgj-20230430.xsd Edgar Link pending
yijia_i10k-043023_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
yjgj-20230430_def.xml Edgar Link unprocessable
yjgj-20230430_pre.xml Edgar Link unprocessable
yjgj-20230430_cal.xml Edgar Link unprocessable
yjgj-20230430_lab.xml Edgar Link unprocessable